Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Asset Resilience Ratio
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) has an Asset Resilience Ratio of 0.62% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Gen Ilac ve Saglik Urunleri Sanayi ve Ti (GENIL) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Gen Ilac ve Saglik Urunleri Sanayi ve Ti (GENIL) total assets.
Liquid Assets Composition Over Time
This chart breaks down Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read GENIL current and long-term liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | TL0.00 | 0% |
| Short-term Investments | TL106.64 Million | 0.62% |
| Total Liquid Assets | TL106.64 Million | 0.62% |
Asset Resilience Insights
- Limited Liquidity: Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS maintains only 0.62% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Industry Peers by Asset Resilience Ratio
Compare Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2022–2024)
The table below shows the annual Asset Resilience Ratio data for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.75% | TL92.52 Million ≈ $2.07 Million |
TL12.31 Billion ≈ $275.73 Million |
-0.08pp |
| 2023-12-31 | 0.83% | TL92.90 Million ≈ $2.08 Million |
TL11.13 Billion ≈ $249.39 Million |
-10.52pp |
| 2022-12-31 | 11.35% | TL418.01 Million ≈ $9.36 Million |
TL3.68 Billion ≈ $82.48 Million |
-- |
About Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV… Read more